West Pharmaceutical Services, Inc. (WST)
- Previous Close
210.59 - Open
214.70 - Bid --
- Ask --
- Day's Range
209.38 - 214.76 - 52 Week Range
187.43 - 372.79 - Volume
905,908 - Avg. Volume
1,170,167 - Market Cap (intraday)
15.414B - Beta (5Y Monthly) 1.22
- PE Ratio (TTM)
33.68 - EPS (TTM)
6.37 - Earnings Date Jul 23, 2025 - Jul 28, 2025
- Forward Dividend & Yield 0.84 (0.39%)
- Ex-Dividend Date Apr 30, 2025
- 1y Target Est
281.83
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
www.westpharma.com10,600
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: WST
View More
Performance Overview: WST
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WST
View MoreValuation Measures
Market Cap
15.41B
Enterprise Value
15.31B
Trailing P/E
33.68
Forward P/E
35.21
PEG Ratio (5yr expected)
3.59
Price/Sales (ttm)
5.44
Price/Book (mrq)
5.75
Enterprise Value/Revenue
5.29
Enterprise Value/EBITDA
20.97
Financial Highlights
Profitability and Income Statement
Profit Margin
16.13%
Return on Assets (ttm)
10.33%
Return on Equity (ttm)
17.42%
Revenue (ttm)
2.9B
Net Income Avi to Common (ttm)
467.2M
Diluted EPS (ttm)
6.37
Balance Sheet and Cash Flow
Total Cash (mrq)
404.2M
Total Debt/Equity (mrq)
11.46%
Levered Free Cash Flow (ttm)
233.51M
Research Analysis: WST
View MoreResearch Reports: WST
View MoreWest Earnings: Adjusted EPS Declined 7% but Full-Year Guidance Revised Upwards
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
RatingPrice TargetRaising target price to $226.00
WEST PHARMACEUTICAL SERVICES has an Investment Rating of HOLD; a target price of $226.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetRaising target price to $223.00
WEST PHARMACEUTICAL SERVICES has an Investment Rating of HOLD; a target price of $223.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetLife Science Industry: Tariffs Remain Concerning, but No Major Change to Our Views Currently
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
RatingPrice Target